The Narrative Review: Advancements in Heart Failure Diagnosis and Management using Artificial Intelligence: A New Era

Sunchandandeep Singh Brar1, Meenakshi Reddy Yathindra2, Juan Sebastian Arias Arango3

  • 1Department of Internal Medicine, China Medical University, Shenyang, China.

Current Cardiology Reviews
|September 15, 2025
PubMed

Insights

Artificial Intelligence (AI) offers advanced solutions for managing Heart Failure (HF). AI improves diagnosis, risk assessment, and personalized treatment, leading to better patient outcomes and healthcare practices.

Area of Science:

  • Cardiology
  • Medical Informatics
  • Artificial Intelligence

Background:

  • Heart Failure (HF) is a growing global health concern with increasing prevalence.
  • Current HF management faces challenges in diagnosis, progression, readmission rates, and therapeutic interventions.
  • Artificial Intelligence (AI) presents promising solutions to enhance HF care.

Purpose of the Study:

  • To review the current progress and future potential of AI in Heart Failure management.
  • To highlight how AI techniques can improve clinical decision-making and patient outcomes.
  • To identify areas for further development in AI for HF treatment.

Main Methods:

  • Review of current AI applications in Heart Failure.
  • Analysis of machine learning and deep learning techniques for diagnosis and risk prediction.
  • Exploration of AI's role in personalized treatment strategies.

Main Results:

  • AI enhances diagnostic accuracy through analysis of medical imaging and electrocardiograms.
  • AI algorithms enable precise risk stratification for personalized treatment plans.
  • AI facilitates early problem identification and selection of appropriate therapies, improving patient outcomes.

Conclusions:

  • AI is crucial for improving Heart Failure management, offering enhanced decision-making and patient care.
  • Further advancements in data integration, predictive accuracy, and ethical considerations are needed.
  • Continued AI development is essential for optimizing Heart Failure treatment and patient outcomes.

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
323
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
261
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
223
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
942
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
422
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
710